查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827739

2025年螢光螢光分析全球市場報告

Immunofluorescence Assay Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，螢光檢測市場規模強勁成長，從2024年的33.4億美元成長到2025年的35.6億美元，複合年成長率為6.5%。歷史時期的成長歸因於疾病診斷的增加、研發的增加、自體免疫疾病的增加、癌症診斷的增加以及病毒學研究的增加。

預計未來幾年螢光螢光檢測市場將快速成長，到2029年將達到53.2億美元，複合年成長率為10.6%。預測期內的成長歸因於個人化醫療的興起、感染疾病監測的加強、自體免疫疾病盛行率的上升、就地檢驗的增加以及全球衛生防備水準的提高。預測期內的主要趨勢包括多重檢測、自動化和機器人技術、高內涵成像、先進的螢光染料以及數位病理學整合。

螢光檢測包括利用此技術觀察受感染細胞內特定蛋白質或抗原的設備和耗材。這種觀察是透過將這些蛋白質或抗原與化學偶聯螢光染料的特異性抗體發生反應來實現的。此實驗室技術用於診斷影響各種器官系統的疾病，包括皮膚、腎臟、心臟和纖毛。

螢光檢測的主要類型是直接螢光和間接螢光。直接螢光是一種用於診斷疾病的實驗室技術，特別是與皮膚、腎臟和其他器官系統相關的疾病。此方法利用與螢光染料直接偶聯的單一抗體。螢光檢測類別涵蓋各種各樣的產品，包括試劑、儀器、抗體、套件、耗材和配件。這些產品用於診斷各種疾病，包括癌症、感染疾病和自體免疫疾病。所調查的目標產品用於學術和研究機構、製藥和生物技術公司、醫院、診斷中心以及合約研究組織。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供螢光測定市場統計數據，包括螢光測定行業的全球市場規模、各地區市場佔有率、各競爭對手的市場佔有率、詳細的螢光螢光測定市場細分、市場趨勢和商機，以及您在螢光測定行業取得成功所需的數據。本螢光測定市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年預測成長率為10.6%，較我們先前對該市場的預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自英國和加拿大等主要地區的螢光標記二抗和高解析度螢光顯微鏡徵收關稅英國影響美國，從而導致診斷準確性降低和病理檢測成本上升。此外，透過互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，這種影響也將更為廣泛地顯現。

螢光螢光檢測市場的強勁成長很大程度上歸功於慢性病的日益普及。生活方式的改變、飲食習慣的改變以及不適當的體重管理導致慢性病發病率激增，而長期感染疾病則會增加癌症風險。由於螢光檢測在慢性病診斷和藥物研發的廣泛應用，其需求正在不斷成長。根據美國美國十個成年人中就有六人患有慢性病，每年的醫療費用高達3.8兆美元。因此，預計慢性病的流行將在整個預測期內推動螢光檢測的需求成長。

由於個人化醫療需求的不斷成長，螢光檢測市場預計將進一步成長。個人化醫療利用個體的基因圖譜為疾病預防、診斷和治療相關的決策提供資訊，這在很大程度上依賴於螢光檢測。這些檢測在識別特定生物標記方面發揮關鍵作用，而這些生物標記對於制定個人化治療計劃至關重要。根據個人化醫療聯盟的報告，將有超過 75,000 種基因檢測產品和 300 多種個人化藥物可用於治療各種疾病，包括癌症、罕見遺傳疾病、慢性病和感染疾病。因此，個人化醫療需求的不斷成長正在推動螢光螢光檢測市場的成長。

螢光檢測市場的一個顯著趨勢是注重技術進步。該領域的公司致力於利用先進技術開發創新產品，尤其致力於針對新發病毒（如COVID-19）的診斷。總部位於英國的照護現場開發商LumiraDx於2022年3月獲得其LumiraDx SARS-CoV-2抗原檢測的緊急核准，該檢測是一種微流體螢光檢測方法，用於定性檢測鼻拭子樣本中的核衣殼蛋白抗原。

螢光測定市場的主要企業正策略性地專注於推出全自動解決方案，以最大化市場收益。這些解決方案簡化了整個螢光測試過程，從樣品製備到孵育、清洗和玻片安裝。 2023 年 6 月，美國生命科學和診斷公司 Levity 推出了 UNIQO 160 (CE-IVDR)，這是一種用於自體免疫疾病診斷的自動間接螢光測試 (IIFT) 系統。 UNIQO 160 是一種桌上型設備，它將自動化處理與高品質顯微鏡結合，一次運行最多可處理 160 個原始檢體和 18 張玻片。該系統利用條碼識別單一樣本、試劑和載玻片。

2022年1月，美國生技公司賽默飛世爾科技（Thermo Fisher Scientific）以18.5億美元收購了PeproTech。此次收購旨在透過將新功能整合到其生物科學業務中，增強賽默飛世爾科技對製藥和生物技術客戶的支援能力，這在不斷變化的基因治療領域至關重要。 PeproTech是一家總部位於美國的生命科學公司，提供重組蛋白和ELISA螢光套件。

螢光測定市場的主要公司包括 Thermo Fisher Scientific Inc.、Abcam plc、Bio-Rad Laboratories Inc.、PerkinElmer Inc.、Werfen Company、Merck KGaA、Danaher Corporation、Cell Signaling Technology Inc.、Vector Laboratories Inc.、INOVA Diagnostics Inc.、Sino Biological Inc. Inc.、Rockland Immunochemicals Inc.、Beshir Laboratories Inc.、Fitzgerald Industries International Inc.、 創新、Bostar Biological Technology、Acris Antibodies GmbH、RayBiotech Inc.、Proteintech Group Inc.、Novus Biologicals LLC、R&D Technology Inc.、Ogene Technologies CorporationS. Limited、J. Mitra &Co.Ltd.、EpiGentek Group Inc.、Elabscience Biotechnology Co.Ltd.、Aesku Diagnostics GmbH

預計北美將在2024年成為免疫螢光市場最大的地區，並有望成為預測期內成長最快的地區。螢光螢光檢測市場佔有率報告涵蓋以下地區：亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

螢光測定市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

螢光檢測市場包括間接免疫螢光補體結合 (IF-CF) 和雙重免疫螢光的銷售。該市場的價值為「工廠門口」價值，即商品製造商或創造者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球螢光檢測：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球螢光螢光分析市場：成長率分析
  • 全球螢光螢光分析市場表現：規模與成長，2019-2024
  • 全球螢光螢光分析市場預測：規模與成長，2024-2029年，2034年
  • 全球螢光檢測：總潛在市場（TAM）

第6章 市場細分

  • 全球螢光螢光分析市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 直接螢光
  • 間接螢光
  • 全球螢光螢光分析市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 試劑
  • 裝置
  • 抗體
  • 套件
  • 耗材及配件
  • 全球螢光螢光分析市場：依疾病、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 癌症
  • 感染疾病
  • 心血管疾病
  • 自體免疫疾病
  • 其他疾病
  • 全球螢光螢光分析市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 學術研究機構
  • 製藥和生物技術公司
  • 合約研究組織
  • 醫院和診斷中心
  • 全球螢光螢光分析市場：依直接螢光細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 單步直接測定
  • 多重直接分析
  • 全球螢光螢光分析市場：依間接螢光法細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 單步間接測定
  • 多重間接檢測

第7章 區域和國家分析

  • 全球螢光螢光分析市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球螢光螢光分析市場：依國家、表現及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 螢光螢光分析市場：競爭格局
  • 螢光螢光分析市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abcam plc Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Werfen Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Merck KGaA
  • Danaher Corporation
  • Cell Signaling Technology Inc.
  • Vector Laboratories Inc.
  • INOVA Diagnostics Inc.
  • Sino Biological Inc.
  • Medipan GmbH
  • BioLegend Inc.
  • Jackson ImmunoResearch Laboratories Inc.
  • Rockland Immunochemicals Inc.
  • Bethyl Laboratories Inc.
  • Fitzgerald Industries International Inc.
  • Creative Diagnostics
  • Boster Biological Technology
  • Acris Antibodies GmbH

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年螢光螢光分析市場：提供新機會的國家
  • 2029年螢光螢光分析市場：細分領域帶來新機會
  • 2029年螢光螢光分析市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r21629u

Immunofluorescence assay encompasses both equipment and consumables designed to utilize a technique allowing the visualization of specific proteins and antigens in infected cells. This visualization is achieved through the reaction of these proteins and antigens with specific antibodies, which are chemically conjugated with a fluorescent dye. This laboratory technique is employed in the diagnosis of diseases affecting various organ systems such as the skin, kidney, heart, cilia, and others.

The main types of immunofluorescence assay include direct immunofluorescence and indirect immunofluorescence. Direct immunofluorescence is a laboratory technique specifically used for diagnosing diseases related to the skin, kidney, and other organ systems. In this method, a single antibody directly conjugated to a fluorescent dye is utilized. The diverse range of products in the immunofluorescence assay category includes reagents, instruments, antibodies, kits, consumables, and accessories. These products are employed in the diagnosis of various diseases, including cancer, infectious diseases, autoimmune diseases, among others. Immunofluorescence assay products are utilized by academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic centers, as well as contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The immunofluorescence assay market research report is one of a series of new reports from The Business Research Company that provides immunofluorescence assay market statistics, including immunofluorescence assay industry global market size, regional shares, competitors with an immunofluorescence assay market share, detailed immunofluorescence assay market segments, market trends and opportunities, and any further data you may need to thrive in the immunofluorescence assay industry. This immunofluorescence assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The immunofluorescence assay market size has grown strongly in recent years. It will grow from $3.34 billion in 2024 to $3.56 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increased disease diagnosis, rise in research and development, rise in autoimmune diseases, increased cancer diagnostics, rise in virology research.

The immunofluorescence assay market size is expected to see rapid growth in the next few years. It will grow to $5.32 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing personalized medicine, rising infectious disease surveillance, rising autoimmune disorders, rising point-of-care testing, increasing global health preparedness. Major trends in the forecast period include multiplexing assays, automation and robotics, high-content imaging, advanced fluorophores, digital pathology integration.

The forecast of 10.6% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on fluorophore-labeled secondary antibodies and high-resolution fluorescence microscopes, sourced from key regions such as the UK and Canada, which could lead to compromised diagnostic accuracy and higher pathology expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The robust growth of the immunofluorescence assay market is significantly attributed to the increasing prevalence of chronic diseases. Lifestyle changes, dietary habits, and inadequate weight management contribute to a surge in chronic conditions, with prolonged infections posing a risk of developing cancer. Immunofluorescence assays are witnessing heightened demand for their extensive use in the diagnosis and drug development activities associated with chronic diseases. A study from the Centers for Disease Control and Prevention reveals that around 6 in 10 adults in the USA are affected by chronic diseases, accounting for a substantial annual healthcare cost of $3.8 trillion. Therefore, the escalating prevalence of chronic diseases is anticipated to drive the demand for immunofluorescence assays throughout the forecast period.

The immunofluorescence assay market is poised for further growth due to the increasing demand for personalized medicines. Personalized medicine, utilizing an individual's genetic profile to inform decisions related to disease prevention, diagnosis, and treatment, relies heavily on immunofluorescence assays. These assays play a pivotal role in identifying specific biomarkers crucial for formulating personalized treatment plans. The Personalized Medicine Coalition reports that over 75,000 genetic testing products and 300 personalized medicines will be available for various conditions, including cancer, rare genetic diseases, and chronic and infectious diseases. Consequently, the rising demand for personalized medicines is propelling the growth of the immunofluorescence assay market.

A prominent trend in the immunofluorescence assay market is the emphasis on technological advancements. Companies in this sector are dedicated to developing innovative products with advanced technologies, especially for diagnostic purposes related to emerging viruses like COVID-19. LumiraDx, a UK-based developer of point-of-care diagnostics, received emergency approval for its microfluidic immunofluorescence assay, LumiraDx SARS-CoV-2 Ag Test, designed for the qualitative detection of nucleocapsid protein antigens from nasal swab samples in March 2022.

Major players in the immunofluorescence assay market are strategically focusing on introducing fully automated solutions to maximize their market revenues. Fully automated solutions streamline the entire immunofluorescence testing process, from sample preparation to incubation, washing, and slide mounting. Revvity Inc., a US-based life sciences and diagnostics company, launched UNIQO 160 (CE-IVDR), an automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics in June 2023. UNIQO 160, a tabletop device, integrates automated processing with a high-quality microscope, capable of handling up to 160 main samples and 18 slides in a single run. The system utilizes barcode recognition for individual samples, reagents, and slides.

In January 2022, Thermo Fisher Scientific Inc., a US-based biotechnology firm, acquired PeproTech Inc. for $1.85 billion. This acquisition is intended to enhance Thermo Fisher Scientific Inc.'s ability to support its pharmaceutical and biotech clients by integrating new capabilities into its biosciences business, which is essential for the changing landscape of gene therapies. PeproTech Inc. is a US-based life science company that offers recombinant proteins and ELISA immunofluorescence kits.

Major companies operating in the immunofluorescence assay market include Thermo Fisher Scientific Inc., Abcam plc, Bio-Rad Laboratories Inc., PerkinElmer Inc., Werfen Company, Merck KGaA, Danaher Corporation, Cell Signaling Technology Inc., Vector Laboratories Inc., INOVA Diagnostics Inc., Sino Biological Inc., Medipan GmbH, BioLegend Inc., Jackson ImmunoResearch Laboratories Inc., Rockland Immunochemicals Inc., Bethyl Laboratories Inc., Fitzgerald Industries International Inc., Creative Diagnostics, Boster Biological Technology, Acris Antibodies GmbH, RayBiotech Inc., Proteintech Group Inc., Novus Biologicals LLC, R&D Systems Inc., OriGene Technologies Inc., GenScript Biotech Corporation, MBL International Corporation, Abnova Corporation, Cellabs India Technologies Limited, J. Mitra & Co. Pvt. Ltd., EpiGentek Group Inc., Elabscience Biotechnology Co. Ltd., Aesku.Diagnostics GmbH

North America was the largest region in the immunofluorescence assay market in 2024, and it is also expected to be the fastest-growing region in the forecast period. The regions covered in the immunofluorescence assay market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the immunofluorescence assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The immunofluorescence assay market consists of sales of indirect IF complement-fixation (IF-CF), and double IF. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunofluorescence Assay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunofluorescence assay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunofluorescence assay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunofluorescence assay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Direct Immunofluorescence; Indirect Immunofluorescence
  • 2) By Product: Reagents; Instruments; Antibodies; Kits; Consumables and Accessories
  • 3) By Disease: Cancer; Infectious Disease; Cardiovascular Diseases; Autoimmune Diseases; Other Diseases
  • 4) By End User: Academic And Research Institutions; Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Hospitals And Diagnostic Centers
  • Subsegments:
  • 1) By Direct Immunofluorescence: Single-Step Direct Assays; Multiplex Direct Assays
  • 2) By Indirect Immunofluorescence: Single-Step Indirect Assays; Multiplex Indirect Assays
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abcam plc; Bio-Rad Laboratories Inc.; PerkinElmer Inc.; Werfen Company; Merck KGaA; Danaher Corporation; Cell Signaling Technology Inc.; Vector Laboratories Inc.; INOVA Diagnostics Inc.; Sino Biological Inc.; Medipan GmbH; BioLegend Inc.; Jackson ImmunoResearch Laboratories Inc.; Rockland Immunochemicals Inc.; Bethyl Laboratories Inc.; Fitzgerald Industries International Inc.; Creative Diagnostics; Boster Biological Technology; Acris Antibodies GmbH; RayBiotech Inc.; Proteintech Group Inc.; Novus Biologicals LLC; R&D Systems Inc.; OriGene Technologies Inc.; GenScript Biotech Corporation; MBL International Corporation; Abnova Corporation; Cellabs India Technologies Limited; J. Mitra & Co. Pvt. Ltd.; EpiGentek Group Inc.; Elabscience Biotechnology Co. Ltd.; Aesku.Diagnostics GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunofluorescence Assay Market Characteristics

3. Immunofluorescence Assay Market Trends And Strategies

4. Immunofluorescence Assay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Immunofluorescence Assay Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Immunofluorescence Assay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Immunofluorescence Assay Market Growth Rate Analysis
  • 5.4. Global Immunofluorescence Assay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Immunofluorescence Assay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Immunofluorescence Assay Total Addressable Market (TAM)

6. Immunofluorescence Assay Market Segmentation

  • 6.1. Global Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Immunofluorescence
  • Indirect Immunofluorescence
  • 6.2. Global Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents
  • Instruments
  • Antibodies
  • Kits
  • Consumables and Accessories
  • 6.3. Global Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Infectious Disease
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Other Diseases
  • 6.4. Global Immunofluorescence Assay Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutions
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations
  • Hospitals And Diagnostic Centers
  • 6.5. Global Immunofluorescence Assay Market, Sub-Segmentation Of Direct Immunofluorescence, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Step Direct Assays
  • Multiplex Direct Assays
  • 6.6. Global Immunofluorescence Assay Market, Sub-Segmentation Of Indirect Immunofluorescence, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Step Indirect Assays
  • Multiplex Indirect Assays

7. Immunofluorescence Assay Market Regional And Country Analysis

  • 7.1. Global Immunofluorescence Assay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Immunofluorescence Assay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunofluorescence Assay Market

  • 8.1. Asia-Pacific Immunofluorescence Assay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunofluorescence Assay Market

  • 9.1. China Immunofluorescence Assay Market Overview
  • 9.2. China Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunofluorescence Assay Market

  • 10.1. India Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunofluorescence Assay Market

  • 11.1. Japan Immunofluorescence Assay Market Overview
  • 11.2. Japan Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunofluorescence Assay Market

  • 12.1. Australia Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunofluorescence Assay Market

  • 13.1. Indonesia Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunofluorescence Assay Market

  • 14.1. South Korea Immunofluorescence Assay Market Overview
  • 14.2. South Korea Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunofluorescence Assay Market

  • 15.1. Western Europe Immunofluorescence Assay Market Overview
  • 15.2. Western Europe Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunofluorescence Assay Market

  • 16.1. UK Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunofluorescence Assay Market

  • 17.1. Germany Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunofluorescence Assay Market

  • 18.1. France Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunofluorescence Assay Market

  • 19.1. Italy Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunofluorescence Assay Market

  • 20.1. Spain Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunofluorescence Assay Market

  • 21.1. Eastern Europe Immunofluorescence Assay Market Overview
  • 21.2. Eastern Europe Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunofluorescence Assay Market

  • 22.1. Russia Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunofluorescence Assay Market

  • 23.1. North America Immunofluorescence Assay Market Overview
  • 23.2. North America Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunofluorescence Assay Market

  • 24.1. USA Immunofluorescence Assay Market Overview
  • 24.2. USA Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunofluorescence Assay Market

  • 25.1. Canada Immunofluorescence Assay Market Overview
  • 25.2. Canada Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunofluorescence Assay Market

  • 26.1. South America Immunofluorescence Assay Market Overview
  • 26.2. South America Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunofluorescence Assay Market

  • 27.1. Brazil Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunofluorescence Assay Market

  • 28.1. Middle East Immunofluorescence Assay Market Overview
  • 28.2. Middle East Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunofluorescence Assay Market

  • 29.1. Africa Immunofluorescence Assay Market Overview
  • 29.2. Africa Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunofluorescence Assay Market Competitive Landscape And Company Profiles

  • 30.1. Immunofluorescence Assay Market Competitive Landscape
  • 30.2. Immunofluorescence Assay Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abcam plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Werfen Company Overview, Products and Services, Strategy and Financial Analysis

31. Immunofluorescence Assay Market Other Major And Innovative Companies

  • 31.1. Merck KGaA
  • 31.2. Danaher Corporation
  • 31.3. Cell Signaling Technology Inc.
  • 31.4. Vector Laboratories Inc.
  • 31.5. INOVA Diagnostics Inc.
  • 31.6. Sino Biological Inc.
  • 31.7. Medipan GmbH
  • 31.8. BioLegend Inc.
  • 31.9. Jackson ImmunoResearch Laboratories Inc.
  • 31.10. Rockland Immunochemicals Inc.
  • 31.11. Bethyl Laboratories Inc.
  • 31.12. Fitzgerald Industries International Inc.
  • 31.13. Creative Diagnostics
  • 31.14. Boster Biological Technology
  • 31.15. Acris Antibodies GmbH

32. Global Immunofluorescence Assay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunofluorescence Assay Market

34. Recent Developments In The Immunofluorescence Assay Market

35. Immunofluorescence Assay Market High Potential Countries, Segments and Strategies

  • 35.1 Immunofluorescence Assay Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Immunofluorescence Assay Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Immunofluorescence Assay Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer